Early B lymphopoiesis in mammals is induced within the bone marrow (BM) microenvironment, but which cells constitute this niche is not known. Previous studies had shown that osteoblasts (OB) support hematopoietic stem cell proliferation and myeloid differentiation, We now find that purified primary murine OB also support the differentiation of primitive hematopoietic stem cells through lymphoid commitment and subsequent differentiation to all stages of B cell precursors and mature B cells. Lin-Sca-1+Rag-2-BM cell differentiation requires attachment to OB to B cells in vitro, and this developmental process is mediated via VCAM-1, SDF-1 and IL-7 signaling induced by parathyroid hormone (PTH). Addition of cytokines produced by nonosteoblastic stromal cells (c-kit ligand, Il-6, and IL-3) shifted the cultures towards myelopoiesis.
Introduction
It has long been hypothesized that early B lymphopoiesis in mammals is induced within the bone marrow (BM) microenvironment, but which cell or cells specifically constitute this B cell niche is not known. Osteoblasts are the differentiated stromal cell type unique to the bone marrow environment, and therefore are a candidate for a cell type to play a specific role in perhaps multiple stages in hematopoiesis, including perhaps B lymphopoiesis. Previously, we found that purified human osteoblasts play a pivotal role in myelopoiesis, both by secreting numerous hematopoietic cytokines that support terminal neutrophil maturation and support the in vitro expansion of primitive long-term culture initiating cells (LTCIC) 3, 4 . More recently, analyses of bone morphogenetic protein receptor 1A deficient (BMPR1A -/-) mice suggest that increased osteoblast number and/or activity increase the pool size of repopulating hematopoietic stem cells (HSC) in vivo 2 , suggesting that osteoblasts stimulatory effect may extend as far back in hematopoietic differentiation to the level of the uncommitted HSC. Whether osteoblasts play a specific role in supporting and/or directing the differentiation of HSCs to lymphoid commitment and differentiation is, however, less clear.
We sought to test directly whether osteoblasts play a pivotal role in B lymphopoiesis over and above any role in HSC maintenance. To ask whether osteoblasts are sufficient to support and induce HSCs to B lymphopoiesis, we have measured the production of early B cell precursors from enriched HSCs cultured on purified osteoblasts in vitro. Conversely, to ask whether osteoblasts are necessary to support and induce HSCs to B lymphopoiesis, osteoblasts are necessary for early B lymphopoiesis, we have examined early alterations in hematopoiesis immediately following osteoblast depletion in Col2.3∆-TK transgenic mice treated with GCV 5 .
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The results of these studies show that osteoblasts are both necessary and sufficient for the support of all stages of B lymphopoiesis, from the first transition from HSC to common lymphoid progenitor to the generation of mature IgM+ B cells. We therefore conclude that the osteoblast comprises a key component of the bone marrow B cell niche.
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From Osteoblast Deletion in Col1α1TK Transgenic Mice. Six-week-old mice bearing the Col2.3∆TK transgene and aged-matched control CD-1 mice injected intraperitoneally daily with for up to 28 days with 5 mg/kg gancyclovir (GCV) (Cytovene-IV; Roche Pharmaceutical, Nutley, NJ, USA) in saline. Mice were sacrificed at weekly intervals, and hematopoietic cells harvested from all long bones and spleens. Loss of osteoblasts was confirmed by measurement of osteocalcin mRNA in situ.
Ostoblast Isolation and Culture: Osteoblasts were isolated from calvaria of new-born mice by collagenase digestion. Briefly, calvaria of 6 to 8 mice from whom soft-tissue was removed were pre-treated in 50 ml of 10mg/ml collagenase P for 20 minutes at 37 0 C (Roche Applied Science, Indianapolis, IN), to remove residual connective tissue debris. After washing, the treated calvaria were minced into (approx. 1mm
2 ) fragments and digested three times with 50ml of 10mg/ml collagenase P at 37 0 C for 10 to 15 minutes. The supernatants collected from all three digestions were pooled together and centrifuged. The pelleted cells was re-suspended in 10%FCS/α-medium supplemented with ascorbic acid and β-glycerophosphate and kept at culture conditions of 37 0 C and 5% CO 2 . Under these conditions, the cells quickly adhered to the plastic and grew to confluence in 3 to 4 days. Aliquots of the adherent cells were released by digestion with 1mg/ml collagenase P and 0.25% trypsin for immunostaining and in situ mRNA analyses. The maturation and purity of osteoblasts were examined by the in situ detection of osteopontin, as well as by flow cytometric detection of multiple antigens including CD45, PECAM-1, Pan-endo and VCAM-1.
To compare osteoblastic versus adipocytic differentiation of primary calvarial cells, osteoblast differentiation was induced by the addition of 10mM β-glycerol phosphate, 50µM
ascorbate-2-phosphate, 10 -7 M dexamethasone and100ng/ml human BMP-2 into 10%FCS/α-medium for 5 to 6 days until the cells reached confluence, followed by digestion, and replating in the presence of ascorbic acid and β-glycerophosphate as well as 1×10 -7 M PTH for 4 to 5 days.
For adipocytic induction, the primary calvarial cells were cultured in the presence of 10 -7 M dexamethasone and 10µg/ml human insulin for 10 to 14 days 23,24 .
Analysis of osteoblasts by immunohistochemistry, ELISA and intracellar cytokine production. Osteoblasts were pre-seeded onto sterile glass cover slides in 6-well plate for 5 days. Then the glass slides were picked up and fixed and stained by standard immunochemistry procedure. Antibodies against osteopontin, osteocalcin and control IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). (Fig. 1b) .
Interestingly, the osteoblasts expressed VCAM-1, which has been hypothesized to mediate early B precursor adhesion to a previously uncharacterized population of BM stromal cells 9, 10 , as well as Sca-1, CD61, and ICAM-1 (Fig. 1c) . (Figure 1 ). . (Figure 4 ).
When Lin
Next, we investigated which cytokines and adhesion molecules derived from osteoblasts are required for B cell commitment and maturation 16, 17 . Previously, we had demonstrated that SDF-1 is secreted by human osteoblasts, as well as in other BM stromal and endothelial cells 18 .
In addition to high concentrations of SDF-1, we found that the cultivated osteoblasts synthesized and secreted measurable quantities of IL-7 when PTH was added (Fig. 5a ), confirming previous reports that IL-7 is required for early B lymphopoiesis 17 . To examine the relationship between osteoblast development and their ability to synthesize IL-7 and SDF-1, we either induced (by the addition of BMP-2 plus PTH) or inhibited (by the addition of adipocyte-inducing agents insulin plus dexamethasone) osteoblastic differentiation from freshly isolated calvarial cells. Whereas PTH-stimulated, fully differentiated osteoblasts secreted both SDF-1 and IL-7, and induced B lymphopoiesis, inhibition of osteoblast differentiation and support of adipocyte differentiation with insulin and dexamethasone blocked IL-7 production and differentiation of B220 + precursors, despite continued elevated level of SDF-1 (Fig. 5b) . Conversely, inclusion of neutralizing antibodies to control LS/OB cocultures confirmed that IL-7 and SDF-1 as well as TSLP (thymic stromal cell-derived lymphopoietin), but not MCSF, were required for the stimulation of B-cell development by osteoblasts (Fig. 5c ). In addition, we found that inclusion of antibody against either VCAM-1 or integrin α4 significantly reduced the generation of B220 + B lymphocytes, emphasizing the importance of the VCAM-1/integrin α4 ligation-mediated signaling in the contact-mediated induction of B lymphopoiesis by OB (Fig. 5d) . (Figure 5 ).
For Figure 6 ). Osteocalcin-specific osteoblasts were depleted as early as 8 days following gancyclovir (GCV) treatment. In parallel, total BM hematopoietic cellularity, but not splenic cellularity, declined by 50% during this 8 day GCV treatment (Fig. 6a) subsets by day 8, with the greatest reduction in pre-pro-B (64%) and pro-B (81%) cells (Fig. 6b) .
Consistent with previous findings showing that osteoblasts support in vitro myeloid progenitor
survival/expansion 4 , the number of Gr-1 lo c-Kit + myeloid progenitors in the BM was also reduced (60%), as were the number of mature monocytes and granulocytes by 28% and 42%, respectively (Fig. 6c) . Erythroid (gly A+) and megakaryocytic (CD41+) cells remained at 90-100% of controls. Despite these effects on B lymphopoiesis, and to a lesser extent on myelopoiesis, the number of Lin -Sca-1 + c-Kit + (LSK) cells, which includes both long-term and short-term HSCs, was not yet reduced by day 8 after osteoblast depletion with GCV (Fig. 6d) .
In contrast, LSK cells were not detectably depleted until day 21 (Fig. 7a ) 5 . Of note, the number of mature B lymphocytes in the spleen did not decline at day 8 ( Fig. 7b) , underscoring the organspecific depletion of early stages of B cells from BM tissue by GCV treatment. These results confirm that osteoblasts play a direct role in BM B cell precursor production, beyond simply supporting HSC survival. Continued evaluation over 28 days following osteoblast depletion confirmed that BM pre-pro B and pro B subsets continued to decline further and more rapidly than LSK, with BM pre-pro and pro-B cells falling to less than 1% of control by 28 days (Fig.   7a,c,d ). These data indicate that acute depletion of osteoblasts causes an abrupt decline in B cell precursors in the bone marrow, confirming their ability to directly support B lymphopoiesis.
( Figure 7 ). Thus, osteoblasts appear to be able to support all developmental transitions in B lymphopoiesis.
DISCUSSION
What molecular events are required for each step is at present uncertain, but the present system should allow for its careful molecular dissection in the future.
Several previous studies had suggested that osteoblasts contribute to both HSC proliferation and myeloid differentiation [1] [2] [3] [4] . The present results also confirm and extend the studies of Visnjic et al., who showed that osteoblasts are required for HSCs in vivo, as their postnatal depletion leads to widespread hematopoietic failure, including the loss of HSCs, myeloid progenitors and precursors, and B lymphoid precursors over one month 5 . Although the most parsimonious explanation for these findings was that HSC loss led to multilineage hematopoietic failure, the present studies demonstrate that the loss of B cell precursors following osteoblast depletion actually precedes any detectable loss of HSCs, and is detectable as soon as maximal osteoblast depletion can be documented, at day 8. In addition, throughout the lifetime of the mice after osteoblast depletion, the degree of B precursor depletion exceeds the reduction in HSC numbers. These results strongly suggest that osteoblasts are essential for some aspects of B lymphopoiesis, over and above any role they may play in HSC maintenance and/or proliferation.
Of course, our data also demonstrate that OB support the production of myeloid precursors in One key implication of these data is that bone formation is directly linked to the integrity of the humoral immune system. This finding therefore raises the possibility that deficiencies in osteoblast number or function might underlie deficiencies in B cell production. Such a decline could, for example, contribute to the decline in humoral immunity seen in aging. At a more speculative level, since osteoblast depletion prevents the earliest detectable transitions from the HSC compartment, it is likewise formally possible that declines in osteoblast function might lead to declines in the number of available T cell progenitors available for emigration to the thymus.
Overall, our data suggest that the further characterization of the diverse effects of osteoblasts on HSC fate decision, survival and differentiation will greatly improve our understanding of local topological mechanisms regulating stem cell lineage commitment and differentiation. For personal use only. on October 24, 2017. by guest www.bloodjournal.org From
